Major Depressive Disorder is the leading cause of disability among women of reproductive age.
Although 90% of women and OB/Gyns will participate in depression screening, it does not improve treatment entry or outcome. 6, 7 Despite the availability of effective evidence-based treatments 8 and frequent contact with OB/Gyn providers, perinatal depression remains underdiagnosed and under-treated. 5, [9] [10] [11] Understanding the perceptions of women who have experienced perinatal depression may inform needed changes in screening, assessment, treatment, and prevention.
Research Goals
1. Identify barriers women with perinatal depression encounter in accessing and following through with depression treatment. 2. Elicit ways in which barriers to the treatment of perinatal depression can be overcome in obstetric settings to facilitate the participation of perinatal women in treatment.
Study Design
This study is a collaborative effort between University of Massachusetts Medical School researchers and the leadership of MotherWoman, a community-based organization in Amherst, Massachusetts that supports and empowers mothers and provides Postpartum Depression trainings for healthcare professionals.* Researchers are conducting four, two-hour focus groups with women who self-identify as having experienced depression and/or anxiety during pregnancy and/or the postpartum period. Participants are recruited from MotherWoman networks across Western Massachusetts.
Anticipated Contribution to Postpartum Treatment for Perinatal Women:
Findings from this study will:
• Contribute to the understanding of barriers that perinatal women experience when accessing depression care.
• Provide preliminary data for the development of strategies to improve the delivery of depression care in obstetric settings.
